Genome & Company Decides on 27.1 Billion KRW Third-Party Allotment Capital Increase
On April 24, Genome & Company announced that it has decided to raise approximately 27.1 billion KRW through a third-party allotment capital increase, including funds for acquiring securities of other corporations. A total of 8,946,866 new shares (other shares) will be issued at 3,025 KRW per share. The third-party allotment recipients include Korea Investment Bio Global Fund (1,195,642 shares) and SV Scale-up Fund (996,328 shares), among others. The company stated that the purpose of the third-party allotment capital increase is "to raise funds to achieve the company's business objectives."
Hot Picks Today
![Even With a 900 Million Won Deposit and 2.5 Million Won Monthly Living Expenses, Residents Say "It's Good to Be Taken Care Of"... Inside a Luxury Silver Town [Opening Silver Housing]](https://cwcontent.asiae.co.kr/asiaresize/93/2026042010015932171_1776646918.gif)
Even With a 900 Million Won Deposit and 2.5 Mil...
- "Over 20 Times More Than Overseas": 104.5 Million Tons of Rare Mineral Discovere...
- [New York Stock Market] Iran Remains Silent Ahead of Ceasefire Expiration... All...
- "When the Middle East War Ends, This Stock Will Lead"... Target Price Raised 71%...
- "Please Launch It in Korea!" After All the Hype... This Coffee Finally Arrives i...
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
